The rise and fall of 23andMe: How DNA testing startup 23andMe went from $6 billion valuation to penny stock
23andMe, a genetic testing company that was once riding high with a valuation, is now fighting for its survival. Only a short while back, 23andMe stood out as one of Silicon Valley’s most promising startups. However, the DNA testing firm
The post The rise and fall of 23andMe: How DNA testing startup 23andMe went from $6 billion valuation to penny stock first appeared on TechStartups.
23andMe, a genetic testing company that was once riding high with a valuation, is now fighting for its survival. Only a short while back, 23andMe stood out as one of Silicon Valley’s most promising startups. However, the DNA testing firm […]
The post The rise and fall of 23andMe: How DNA testing startup 23andMe went from $6 billion valuation to penny stock first appeared on TechStartups.